News

Investors Urged to Review Rights in Class Action Lawsuits

Investors Urged to Review Rights in Class Action Lawsuits

Understanding Class Action Lawsuits

Class action lawsuits arise when a group of people collectively bring a claim to court, often for similar grievances against a corporation or entity. These actions ensure that individuals affected by corporate wrongdoing can pursue justice and seek compensation as a unified front.

Recent Class Action Reminders

Bragar Eagel & Squire, P.C., a prominent law firm specializing in shareholder rights, is reaching out to investors in several notable companies, including Jasper Therapeutics, Inc. (NASDAQ: JSPR), KBR, Inc. (NYSE: KBR), Spirit Aviation Holdings, Inc. (OTC: FLYYQ), and Molina Healthcare, Inc. (NYSE: MOH). This reminder encourages investors to be aware of upcoming deadlines and their rights related to the filed class actions.

Jasper Therapeutics, Inc. (NASDAQ: JSPR)

The class period for Jasper Therapeutics spans from November 30, 2023, to July 3, 2025. The firm has highlighted several key allegations against the company. Investors have until November 18, 2025, to petition the court to act as lead plaintiff. Allegations include the lack of adequate manufacturing controls that led to misleading statements regarding the company’s product trials and prospects. This has raised concerns about Jasper's transparency with its investors.

KBR, Inc. (NYSE: KBR)

Similar legal challenges apply to KBR, where the class period runs from May 6, 2025, to June 19, 2025. The lead plaintiff deadline is also set for November 18, 2025. Investors have alleged that KBR misinformed them about the company’s partnership with the U.S. Department of Defense. It is claimed that KBR was aware of operational issues yet presented a misleadingly positive narrative to shareholders, which ultimately resulted in financial damages once the truth surfaced.

Spirit Aviation Holdings, Inc. (OTC: FLYYQ)

For Spirit Aviation, the class period ranges from May 28 to August 29, 2025, with a lead plaintiff deadline of December 1, 2025. The complaint emphasizes significant financial distress following Spirit’s bankruptcy reorganization in April 2025. Allegations in the lawsuit maintain that the company had significantly overstated its financial health, leading to a steep decline in stock price after the public disclosures were made.

Molina Healthcare, Inc. (NYSE: MOH)

The Molina Healthcare class action's period runs from February 5 to July 23, 2025, with a lead plaintiff deadline of December 2, 2025. Investors allege that the company failed to disclose critical information that could negatively affect its market performance, particularly concerning medical cost trends and market conditions. Investors face considerable challenges, contemplating how these undisclosed facts may impact company growth and their financial interests.

Contact Bragar Eagel & Squire, P.C.

The firm is inviting any investors impacted by these events to reach out for guidance on their legal rights and possible participation in the class actions. Bragar Eagel & Squire, P.C. operates nationwide, advocating for individuals who have suffered from corporate malfeasance. For more information, interested parties can contact them directly.

Frequently Asked Questions

What is a class action lawsuit?

A class action lawsuit is a legal action taken by a group of individuals collectively against a defendant, typically a corporation, for similar damages or grievances.

How can I know if I'm part of a class action?

Investors affected by specific corporate actions are typically notified through legal announcements or through their investment firms. Consulting legal counsel is a prudent way to understand individual rights.

What should I do if I wish to participate?

If you believe you are affected, it's essential to contact a law firm handling the class action to understand your rights and the necessary steps to take.

How long do I have to file?

Each case has specific deadlines known as lead plaintiff deadlines. For current cases, these deadlines are crucial and require prompt action.

Can I still join if I missed the lead plaintiff deadline?

While the lead plaintiff has specific responsibilities, other affected investors may still have opportunities to join class actions or file separate lawsuits based on the circumstances.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of $100 Investment in TD Synnex - A 20-Year Review

Updated Category News Views 201

Understanding the Value of Long-Term Investments Investing can often feel daunting, but the story of TD Synnex (NYSE: SNX) illustrates the powerful potential of long-term commitment. Over the last two decades, the company's stock has outperformed the broader market, delivering compelling returns to its investors. The Journey of TD Synnex Over the Past 20 Years During this...

Continue Reading
Growth of Nuclear Medicine Software Market Expected to Surge

Updated Category News Views 101

Emerging Trends in the Nuclear Medicine Software Market The nuclear medicine software market is poised for significant growth, projected to reach approximately US$1,491.55 million by 2030. This represents a compound annual growth rate (CAGR) of 9.0% from its current valuation. As healthcare continues to evolve, the demand for precise and early diagnostics is paramount,...

Continue Reading
Quanterix Corporation Faces Investigation Amid Investor Concerns

Updated Category News Views 400

Quanterix Corporation Faces Scrutiny from Rosic Law Firm In a recent development, Quanterix Corporation (NASDAQ: QTRX) has come under investigation by the Rosen Law Firm. This esteemed global investor rights law firm is exploring potential securities claims on behalf of the company's shareholders. The investigation arises from allegations of misleading business...

Continue Reading
Navigating Market Dynamics: Strategies for Today's Investors

Updated Category News Views 139

Understanding Market Strategies To excel in today's stock market, it's essential to have a keen understanding of various investment strategies. The current landscape suggests that savvy investors can find profitable opportunities even amid volatility. Taking Advantage of Hedges In light of recent sell-offs, a prudent strategy involves taking partial profits on hedges....

Continue Reading
Celebrate the Magic of Middle-earth: A Unique Reunion Tour

Updated Category News Views 246

FAN EXPO Celebrates 25 Years of The Lord of the Rings FAN EXPO HQ is thrilled to announce a special celebration marking the 25th anniversary of the iconic film, The Lord of the Rings. This memorable event, titled An Evening with the Hobbits: In Celebration of 25 Years, will take place in 11 cities across North America, starting in January. Key cast members Elijah Wood,...

Continue Reading